News and Updates
June 3rd 2019
iVeena announces the addition of internationally known Key Opinion Leader and entrepreneur, Dr. Richard Lindstrom, MD to the iVeena Scientific Advisory Board.
Read about Dr. Lindstrom
May 20th 2019
iVeena awarded top prize for most promising new products in the field of ophthalmology at the American Society of Cataract and Refractive Surgeons annual conference.
iVeena receives top award at the American Society of Cataract and Refractive Surgeons At the May 4, 2019 American Society of Cataract and Refractive Surgeons, Dr. Ambati (iVeena President and Founde...
February 4th 2019
iVeena announces the commencement of a 36 patient Phase 1/2a pilot clinical study for the treatment of keratoconus.
iVeena announces the commencement of a 36 patient Phase I/2a pilot clinical study for the treatment of Keratoconus (IVMED-80). The Company has Orphan Drug Designation for this product. Keratoconus...
February 4th 2019
Mountain Pacific Venture Fund invests in ocular drug development company iVeena
iVeena announces the first close for its $2.75M Series B financing by Mountain Pacific Venture Fund, a health care/biotech focused venture fund. Press release attached or continue below: Contact...
April 12th 2018
Dr. Bala Ambati, President and Founder of iVeena, provides update of iVeena activities at the recent OIS (Ophthalmology Innovation Summit) meeting in Washington, DC.
View the presentation at https://www.youtube.com/embed/mZqwcWkOmzE
Page 4 of 9